Multiple Sclerosis Trial, Not Yet Recruiting NCT07152145 Sponsor: Parc de Salut Mar Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07152145
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 70 years.
  • People who have been diagnosed with Multiple Sclerosis (MS), based on a specific set of diagnostic guidelines called the revised McDonald criteria.
  • People whose hand and arm function is affected, shown by taking notably longer than average on a standard hand coordination test called the 9-Hole Peg Test (at least 20% slower than the typical result for someone of their age).
  • People whose MS medication has remained the same for at least 6 months before joining the trial.
  • People whose level of MS-related disability falls within a specific mid-range on a standard disability scale used by neurologists (confirm with trial site).
  • People who are able to read, understand, and agree to take part in the trial in writing.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had an MS relapse, or have been treated with steroid medications, within the past 3 months.
  • People who have severe muscle stiffness in their arms and hands, as measured by a standard clinical scale (confirm with trial site).
  • People who have an implanted electrical device in their body, such as a pacemaker or a spinal cord stimulator.
  • People who have epilepsy or seizures that are not well controlled.
  • People who have a serious psychiatric condition or significant memory or thinking difficulties that would affect their ability to take part in study procedures.
  • Women who are currently pregnant or breastfeeding.
  • People who have taken part in another interventional clinical trial within the past 3 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Parc de Salut Mar
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change in Upper Limb Function (9-Hole Peg Test)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov